Effect of Pentoxifylline + CoQ10 vs CoQ10 Alone on Sperm Motility in Subfertile Men With Asthenozoospermia

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age20-50
SponsorMst.Sumyara Khatun

About this trial

The goal of this clinical trial is to learn if drug Pentoxifylline plus Coenzyme Q10 work to treat asthenozoospermia in subfertile male. It will also learn about the safety of drug Pentoxifylline plus Coenzyme Q10. The main questions it aims to answer are:

Does drug Pentoxifylline plus Coenzyme Q10 increase the motility of sperm in participants? What medical problems do participants have when taking drug Pentoxifylline plus Coenzyme Q10 ? Researchers will compare drug Pentoxifylline plus Coenzyme Q10 combination to Coenzyme Q10 alone to see if drug Pentoxifylline plus Coenzyme Q10 combination works better.

Participants will:

Experimental Group:Pentoxifylline 400mg twice dailyand Coenzyme Q10 100mg twice daily for 3 months.

Comparator Group: Coenzyme Q10 100mg twice daily for 3 months Visit the clinic after three months of treatment for checkups and tests

Eligibility criteria

Qualifiers

Sub fertile men with asthenozoospermia(Total motility20% to less than 42%) according to WHO semen analysis,2021.

Age 20-50 years.

Disqualifiers

Severe oligoasthenoteratozoospermia

Any medical, endocrine and genetic disorders, history of chemotherapy or radiotherapy, genital infection, genital surgery.

Antioxidants supplmentation in the last 3 months

Drug, alcohol or substance abuse, psycho-sexual abnormalities.

Trial design

Treatments tested in this trial

  • Coenzyme Q 10
  • Pentoxifylline 400 MG Oral Tablet

Treatment groups

56 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Mst.Sumyara Khatun

Lead sponsor

Bangladesh Medical University

Sponsor institution

Bangladesh Medical University

Collaborator